-+ 0.00%
-+ 0.00%
-+ 0.00%

Connect Biopharma Highlights Rademikibart’s Differentiation and Clinical Progress in Asthma, COPD, and Atopic Dermatitis

Reuters·01/12/2026 13:22:57

Please log in to view news